Noriyo Nagata
About
Noriyo Nagata is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Noriyo Nagata has authored 116 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 39 papers in Epidemiology and 30 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Noriyo Nagata's work include SARS-CoV-2 and COVID-19 Research (35 papers), Viral Infections and Immunology Research (30 papers) and Viral gastroenteritis research and epidemiology (29 papers). Noriyo Nagata is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (35 papers), Viral Infections and Immunology Research (30 papers) and Viral gastroenteritis research and epidemiology (29 papers). Noriyo Nagata collaborates with scholars based in Japan, United States and France. Noriyo Nagata's co-authors include Makoto Takeda, Hideki Hasegawa, Naoko Iwata‐Yoshikawa, Kazuya Shirato, Shutoku Matsuyama, Miyuki Kawase, Tetsutaro Sata, Yasushi Ami, Yuriko Suzaki and Fumihiro Taguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.
In The Last Decade
Noriyo Nagata
114 papers receiving 6.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Noriyo Nagata Japan | 41 | 4.1k | 1.6k | 1.3k | 1.2k | 817 | 116 | 6.2k | ||
| Katja C. Wolthers Netherlands | 39 | 3.9k 0.9× | 2.7k 1.7× | 603 0.5× | 2.3k 1.8× | 963 1.2× | 134 | 6.6k | ||
| Atsushi Okumura United States | 33 | 2.9k 0.7× | 855 0.5× | 714 0.6× | 466 0.4× | 1.0k 1.3× | 98 | 5.2k | ||
| Adam S. Lauring United States | 36 | 2.6k 0.6× | 1.3k 0.8× | 1.4k 1.1× | 321 0.3× | 524 0.6× | 98 | 5.1k | ||
| Chuan‐Liang Kao Taiwan | 40 | 3.1k 0.8× | 1.1k 0.7× | 859 0.7× | 837 0.7× | 658 0.8× | 130 | 5.4k | ||
| Richard Molenkamp Netherlands | 36 | 2.8k 0.7× | 1.8k 1.1× | 543 0.4× | 678 0.5× | 313 0.4× | 120 | 4.5k | ||
| Miguel Ángel Martı́nez Spain | 43 | 2.0k 0.5× | 1.0k 0.6× | 1.8k 1.4× | 1.1k 0.9× | 391 0.5× | 172 | 6.0k | ||
| Ralf Altmeyer France | 31 | 2.0k 0.5× | 778 0.5× | 934 0.7× | 494 0.4× | 749 0.9× | 58 | 3.8k | ||
| Masayuki Shimojima Japan | 35 | 2.8k 0.7× | 1.2k 0.7× | 553 0.4× | 435 0.3× | 547 0.7× | 155 | 4.3k | ||
| Julian A. Hiscox United Kingdom | 43 | 3.0k 0.7× | 1.0k 0.6× | 1.7k 1.3× | 573 0.5× | 597 0.7× | 145 | 5.5k |
Countries citing papers authored by Noriyo Nagata
Since
Specialization
Citations
This map shows the geographic impact of Noriyo Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriyo Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriyo Nagata more than expected).
Fields of papers citing papers by Noriyo Nagata
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Noriyo Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriyo Nagata. The network helps show where Noriyo Nagata may publish in the future.
Co-authorship network of co-authors of Noriyo Nagata
This figure shows the co-authorship network connecting the top 25 collaborators of Noriyo Nagata. A scholar is included among the top collaborators of Noriyo Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriyo Nagata. Noriyo Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Li, You, Ling Xie, Maryna Kapustina, et al.. (2025). Heat shock protein 90 chaperone activity is required for hepatitis A virus replication. Journal of Virology. 99(7). e0050225–e0050225.
2.
Kakizaki, Masatoshi, Rina Hashimoto, Noriyo Nagata, et al.. (2024). The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids. Journal of Virology. 99(1). e0185324–e0185324.
3.
Adachi, Yu, Taishi Onodera, Naoko Iwata‐Yoshikawa, et al.. (2023). High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection. Biochemical and Biophysical Research Communications. 673. 114–120.
4.
Kurosu, Takeshi, Daisuke Okuzaki, Yusuke Sakai, et al.. (2023). Dengue virus infection induces selective expansion of Vγ4 and Vγ6TCR γδ T cells in the small intestine and a cytokine storm driving vascular leakage in mice. PLoS neglected tropical diseases. 17(11). e0011743–e0011743.
5.
Iwata‐Yoshikawa, Naoko, Tsuyoshi Sekizuka, Kaori Sano, et al.. (2022). A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection. Science Advances. 8(1). eabh3827–eabh3827.
6.
Rimbara, Emiko, Masato Suzuki, Hidenori Matsui, et al.. (2021). Isolation and characterization ofHelicobacter suisfrom human stomach. Proceedings of the National Academy of Sciences. 118(13).
7.
El‐Kafrawy, Sherif A., Aymn T. Abbas, Sayed Sartaj Sohrab, et al.. (2021). Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection. Pharmaceuticals. 14(6). 511–511.
8.
Abbas, Aymn T., Sherif A. El‐Kafrawy, Sayed Sartaj Sohrab, et al.. (2020). Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model. Vaccines. 8(4). 634–634.
9.
Iwata‐Yoshikawa, Naoko, Shuetsu Fukushi, Hideki Tani, et al.. (2019). Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiology and Immunology. 64(1). 33–51.
10.
Iwata‐Yoshikawa, Naoko, Tadashi Okamura, Yukiko Shimizu, et al.. (2019). Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus. Journal of Virology. 93(6).
11.
Nagata, Noriyo, Masayuki Saijo, Michiyo Kataoka, et al.. (2014). Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.. PubMed. 7(7). 4359–70.
12.
Yoshii, Kentaro, Noriyo Nagata, Takahiro Sanada, et al.. (2013). Genetic and Biological Characterization of Tick-Borne Encephalitis Virus Isolated from Wild Rodents in Southern Hokkaido, Japan in 2008. Vector-Borne and Zoonotic Diseases. 13(6). 406–414.
13.
Hayasaka, Daisuke, Noriyo Nagata, Hideki Hasegawa, et al.. (2010). Early Mortality Following Intracerebral Infection with the Oshima Strain of Tick-Borne Encephalitis Virus in a Mouse Model. Journal of Veterinary Medical Science. 72(4). 391–396.
14.
Saijo, Masayuki, Yasushi Ami, Yuriko Suzaki, et al.. (2009). Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. Journal of General Virology. 90(9). 2266–2271.
15.
Iizuka, Itoe, Masayuki Saijo, Tomoyuki Shiota, et al.. (2009). Loop‐mediated isothermal amplification‐based diagnostic assay for monkeypox virus infections. Journal of Medical Virology. 81(6). 1102–1108.
16.
Saijo, Masayuki, Yasushi Ami, Yuriko Suzaki, et al.. (2008). Diagnosis and Assessment of Monkeypox Virus (MPXV) Infection by Quantitative PCR Assay: Differentiation of Congo Basin and West African MPXV Strains. Japanese Journal of Infectious Diseases. 61(2). 140–142.
17.
Saijo, Masayuki, Yasushi Ami, Yuriko Suzaki, et al.. (2006). LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox. Journal of Virology. 80(11). 5179–5188.
18.
Hansman, Grant S., Katsuro Natori, Oka T, et al.. (2004). Cross-reactivity among sapovirus recombinant capsid proteins. Archives of Virology. 150(1). 21–36.
19.
Nakajima, Noriko, Yasuko Asahi‐Ozaki, Noriyo Nagata, et al.. (2003). SARS Coronavirus-Infected Cells in Lung Detected by New In Situ Hybridization Technique. Japanese Journal of Infectious Diseases. 56(3). 139–141.
20.
Takeuchi, Kaoru, Naoko Miyajima, Noriyo Nagata, Makoto Takeda, & Masato Tashiro. (2003). Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Research. 94(1). 11–16.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Katja C. Wolthers Breakdown of academic impact, for papers by Atsushi Okumura Breakdown of academic impact, for papers by Adam S. Lauring Breakdown of academic impact, for papers by Chuan‐Liang Kao Breakdown of academic impact, for papers by Richard Molenkamp Breakdown of academic impact, for papers by Miguel Ángel Martı́nez Breakdown of academic impact, for papers by Ralf Altmeyer Breakdown of academic impact, for papers by Masayuki Shimojima Breakdown of academic impact, for papers by Julian A. Hiscox